Table 1.
Differential deuteration in the β-chain of C3- and C3b-derived peptides.
C3 Sequence Number | Chain | Domain | Average Difference in Deuteration a | |
---|---|---|---|---|
MALDI | ESI | |||
1–14 | β | MG1 | n/a | 0.2% |
5–15 | β | MG1 | −5.5% | n/a |
21–47 | β | MG1 | 2.1% | −0.5% |
23–47 | β | MG1 | −1.1% | n/a |
101–108 | β | MG1-2 | n/a | −3.7% |
109–124 | β | MG2 | n/a | −6.7% |
125–142 | β | MG2 | −2.4% | −2.5% |
143–158 | β | MG2 | n/a | 2.4% |
165–176 | β | MG2 | n/a | 9.4% |
177–186 | β | MG2 | −4.0% | n/a |
187–199 | β | MG2 | n/a | −1.7% |
221–230 | β | MG3 | −3.1% | n/a |
235–248 | β | MG3 | −18.9% | n/a |
249–277 | β | MG3 | n/a | −5.4% |
259–277 | β | MG3 | −7.1% | n/a |
307–335 | β | MG3-4 | n/a | −4.9% |
336–352 | β | MG4 | −4.2% | n/a |
336–350 | β | MG4 | n/a | 0.6% |
353–373 | β | MG4 | −2.7% | n/a |
353–387 | β | MG4 | n/a | −2.3% |
388–411 | β | MG4 | −1.5% | 2.6% |
412–436 | β | MG4-5 | −3.4% | 1.8% |
437–453 | β | MG5 | n/a | −2.4% |
440–449 | β | MG5 | −3.7% | n/a |
454–470 | β | MG5 | n/a | 1.9% |
471–491 | β | MG5 | 1.2% | n/a |
472–491 | β | MG5 | n/a | 1.9% |
492–499 | β | MG5 | n/a | 3.0% |
513–526 | β | MG5 | −1.5% | n/a |
542–560 | β | MG6β | n/a | −11.1% |
550–558 | β | MG6β | −24.1% | n/a |
574–599 | β | MG6β-LNK | n/a | −17.7% |
600–622 | β | LNK | n/a | 0.3% |
Average percentage change in amide backbone deuterium level after correction for side chain contributions (MALDI) or deuterium back-exchange (ESI). Positive and negative numbers indicate increased and decreased deuterium incorporation in C3b compared to C3, respectively. Changes greater than ±10% in at least one method were considered significant and are highlighted in bold italic type.